Edmond De Rothschild Holding S.A. Regeneron Pharmaceuticals, Inc. Transaction History

Edmond De Rothschild Holding S.A.

  • $5.87 Billion
  • Q1 2024

A detailed history of Edmond De Rothschild Holding S.A. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Edmond De Rothschild Holding S.A. holds 119 shares of REGN stock, worth $124,314. This represents 0.0% of its overall portfolio holdings.

Number of Shares
119
Previous 111 7.21%
Holding current value
$124,314
Previous $97,000 17.53%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
BUY
$902.69 - $993.35 $7,221 - $7,946
8 Added 7.21%
119 $114,000
Q4 2023

Feb 12, 2024
SELL
$775.18 - $881.7 $8,526 - $9,698
-11 Reduced 9.02%
111 $97,000
Q3 2023

Nov 13, 2023
SELL
$692.45 - $844.37 $6,232 - $7,599
-9 Reduced 6.87%
122 $100,000
Q2 2023

Aug 09, 2023
SELL
$700.03 - $830.35 $23,801 - $28,231
-34 Reduced 20.61%
131 $94,000
Q1 2023

May 11, 2023
SELL
$680.49 - $826.97 $65,327 - $79,389
-96 Reduced 36.78%
165 $135,000
Q4 2022

Feb 09, 2023
BUY
$705.89 - $766.39 $15,529 - $16,860
22 Added 9.21%
261 $188,000
Q3 2022

Nov 09, 2022
SELL
$573.97 - $724.32 $144,066 - $181,804
-251 Reduced 51.22%
239 $165,000
Q2 2022

Aug 12, 2022
SELL
$548.35 - $738.84 $1.07 Million - $1.44 Million
-1,954 Reduced 79.95%
490 $289,000
Q1 2022

May 10, 2022
SELL
$595.12 - $698.43 $1.18 Million - $1.39 Million
-1,990 Reduced 44.88%
2,444 $1.71 Million
Q4 2021

Feb 10, 2022
SELL
$543.48 - $670.97 $465,762 - $575,021
-857 Reduced 16.2%
4,434 $2.8 Million
Q3 2021

Nov 12, 2021
BUY
$574.03 - $680.96 $362,212 - $429,685
631 Added 13.54%
5,291 $3.2 Million
Q2 2021

Aug 11, 2021
SELL
$472.8 - $558.54 $1.13 Million - $1.33 Million
-2,386 Reduced 33.86%
4,660 $2.6 Million
Q1 2021

May 17, 2021
BUY
$446.73 - $548.2 $167,077 - $205,026
374 Added 5.61%
7,046 $3.33 Million
Q4 2020

Feb 12, 2021
SELL
$478.3 - $607.98 $254,933 - $324,053
-533 Reduced 7.4%
6,672 $3.22 Million
Q3 2020

Nov 12, 2020
SELL
$544.75 - $658.21 $159,067 - $192,197
-292 Reduced 3.89%
7,205 $4.03 Million
Q2 2020

Aug 07, 2020
BUY
$493.32 - $643.92 $3.67 Million - $4.8 Million
7,448 Added 15200.0%
7,497 $4.68 Million
Q3 2019

Nov 14, 2019
SELL
$273.46 - $318.39 $13,672 - $15,919
-50 Reduced 50.51%
49 $14,000
Q2 2019

Aug 14, 2019
BUY
$299.6 - $414.82 $14,680 - $20,326
49 Added 98.0%
99 $31,000
Q1 2018

May 15, 2018
SELL
$315.82 - $393.78 $252,656 - $315,024
-800 Reduced 94.12%
50 $17,000
Q3 2017

Nov 13, 2017
BUY
$431.38 - $504.0 $366,673 - $428,400
850
850 $380,000

Others Institutions Holding REGN

# of Institutions
1,426
Shares Held
82.1M
Call Options Held
835K
Put Options Held
1.46M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $112B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Edmond De Rothschild Holding S.A. Portfolio

Follow Edmond De Rothschild Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email